Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi Life Sciences Expects Growth Spurt

Premium

Hitachi, which signed a 10-year instrument development deal with Nanogen last month, is projecting wild growth for its life sciences division. The division combined a corporate infusion with a $9 million grant it received last year from Japan’s Ministry of International Trade and Industry to gear up to tackle the genomics market.

The division has merged with Hitachi’s instruments and information groups in Kawagoe City, and broadened its services to address high-throughput sequencing, SNP scanning and scoring, expression profiling, protein network analysis, and bioinformatics. Jointly with Applied Biosystems, Hitachi recently introduced a 16-capillary small-scale sequencing machine.

Takao Iwayanagi, chief technology officer for the life sciences group says he expects revenues this year of $7.2 million. But by 2002, he expects to multiply that almost 20-fold to reach revenues of $135 million.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.